Expanding medical abortion in Tunisia: women's experiences from a multi-site expansion study

From November 2000 to July 2001, 321 consenting women were enrolled at four sites across the country in an effort to demonstrate that mifepristone medical abortion could safely be used by providers throughout Tunisia. Women who met the study's inclusion criteria were given 200 mg oral mifeprist...

Full description

Saved in:

Bibliographic Details
Published in:	Contraception (Stoneham) Vol. 70; no. 6; pp. 487 - 491
Main Authors:	Hajri, Selma, Blum, Jennifer, Gueddana, Nabiha, Saadi, Habib, Maazoun, Leila, Chélli, Hela, Dabash, Rasha, Winikoff, Beverly
Format:	Journal Article
Language:	English
Published:	New York, NY Elsevier Inc 01-12-2004 Elsevier Science
Subjects:	Abortifacient Agents, Nonsteroidal - administration & dosage Abortion, Induced - methods Abortion, Induced - psychology Administration, Oral Adult Biological and medical sciences Birth control Developing countries Female Gynecology. Andrology. Obstetrics Health Services Accessibility - statistics & numerical data Humans Induced abortion. Therapeutic abortion Medical abortion Medical sciences Mifepristone Mifepristone - administration & dosage Misoprostol Office Visits - statistics & numerical data Patient Satisfaction Pregnancy Safety Tunisia - epidemiology Tunisia Africa Developing countries Mifepristone Misoprostol Medical abortion Human Abortifacient Antiprogesterone Induced abortion Female Prostaglandin derivatives
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!